Novel mechanisms and devices to enable successful transdermal drug delivery

European Journal of Pharmaceutical Sciences

Volumn 14, Issue 2, 2001, Pages 101-114

  Barry, B W ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Iontophoresis; Liposomes; Review; Skin enhancement; Ultrasound

Indexed keywords

ABLATION; HYDRATION; OPTIMIZATION; TISSUE; ULTRASONICS;

DRUG-VEHICLE INTERACTION;

CONTROLLED DRUG DELIVERY;

2 PYRROLIDONE DERIVATIVE; ALCOHOL; DIMETHYL SULFOXIDE; DRUG VEHICLE; ETHOSOME; FATTY ACID; HYDROCARBON; ION; LIPOSOME; NIOSOME; PENETRATION ENHANCING AGENT; PRODRUG; SURFACTANT; TRANSFERSOME; UNCLASSIFIED DRUG; WATER;

DEVICE; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; ELECTRICITY; ELECTROPORATION; HUMAN; HYDRATION; IONTOPHORESIS; MAGNETOPHORESIS; MEMBRANE PERMEABILITY; NEEDLE; PHYSICAL PHENOMENA; PRIORITY JOURNAL; REVIEW; SKIN; SKIN PENETRATION; STRATUM CORNEUM; TECHNIQUE; TRANSDERMAL DRUG ADMINISTRATION; ULTRASOUND;

ADMINISTRATION, CUTANEOUS; ANIMALS; DRUG DELIVERY SYSTEMS; ELECTROPORATION; HUMANS; IONTOPHORESIS; LIPOSOMES; PHONOPHORESIS; SKIN ABSORPTION;

EID: 0034902043     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(01)00167-1     Document Type: Review

References (203)

1. Skin reactions. XII. Patterns produced in the skin by electrophoresis of dyes
2. The pilosebaceous unit: a pivotal route for topical drug delivery
3. Skin distribution and pharmaceutical aspects of adapalene gel
4. Effect of pulsed output ultrasound on the transdermal absorption of indomethacin from an ointment in rats
5. Enhancement of transdermal drug delivery: chemical and physical approaches
6. Percutaneous penetration enhancers: local versus transdermal activity
7. Contributions of drug solubilisation, partitioning, barrier disruption and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines
8. Enhancement of transdermal iontophoretic delivery of a liposomal formulation of colchicine by electroporation
9. Iontophoresis and electroporation: comparisons and contrasts
10. Action of skin penetration enhancers - the lipid protein partitioning theory
11. Lipid-protein partitioning theory of skin penetration enhancement
12. Permeation enhancement through skin
13. Physical and physiological effects of stratum corneum tape stripping
14. Visualisation and analysis of electroosmotic flow in hairless mouse skin
15. Mechanism of transport enhancement of LHRH through porcine epidermis by terpenes and iontophoresis: permeability and lipid extraction studies
16. Synergistic effect of iontophoresis of a series of fatty acid on LHRH permeability through human skin
17. Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro
18. Effects of size and sequence on the iontophoretic delivery of oligonucleotides
19. Occlusion does not uniformly enhance penetration in vivo
20. Transdermal and transmucosal powdered drug delivery
21. Characterisation of the permselective properties of excised human skin during iontophoresis
22. Characterisation of the pore transport properties and tissue alteration of excised human skin during iontophoresis
23. The use of ultrasound as an enhancer for transcutaneous drug delivery: phonophoresis
24. Ultrasound
25. 3 as a tracer molecule
26. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery
27. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradient and hydration force
28. Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo
29. The skin: a pathway for systemic treatment with patches and lipid-based carriers
30. Transdermal drug carriers: basic properties, optimisation and transfer efficiency in the case of epicutaneously applied peptides
31. The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones
32. Enhancement of skin permeation
33. Charged microbeads are not transported across the human stratum corneum in vitro by short high-voltage pulses
34. Bioavailability assessment of topical delivery systems: effect of vehicle evaporation upon in vitro delivery of minoxidil from solution formulations
35. Effects of pH, electric current, and enzyme inhibitors on iontophoresis of delta sleep-inducing peptide
36. The pretreatment effect of chemical skin penetration enhancers in transdermal drug delivery using iontophoresis
37. Enhancement of percutaneous absorption by the use of volatile: nonvolatile systems as vehicles
38. Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil
39. Modes of action of terpene penetration enhancers in human skin: differential scanning calorimetry, small-angle X-ray diffraction and enhancer uptake studies
40. Wide-angle X-ray diffraction of human stratum corneum: effects of hydration and terpene enhancer treatment
41. Sites of iontophoretic current flow into the skin: identification and characterisation with the vibrating probe electrode
42. Non-invasive assessment of the effects of iontophoresis on human skin in vivo
43. Effect of supersaturation on membrane transport: 1. Hydrocortisone acetate
44. Carriers for skin delivery of trihexyphenidyl HCI: ethosomes vs. liposomes
45. Intradermal DNA immunization of mice against influenza A virus using the novel PowderJect (R) system
46. Characterisation of convective solvent flow during iontophoresis
47. Lasers in skin resurfacing
48. Skin delivery of estradiol from deformable and traditional liposomes: mechanistic studies
49. Skin delivery of estradiol from ultradeformable liposomes: refinement of surfactant concentration
50. Skin delivery of estradiol from lipid vesicles: importance of liposome structure
51. Immunization via hair follicles by topical application of naked DNA to normal skin
52. Transdermal delivery of sodium nonivamide acetate from volatile vehicles: effects of polymers
53. Application of liposomes as potential cutaneous drug delivery systems: in vitro and in vivo investigation with radioactivity labelled vesicles
54. Skin care and the topical treatment of aging skin
55. Lipid-protein partitioning (LPP) theory of skin enhancer activity: finite dose technique
56. Pathways of ionic flow through human skin in vivo
57. Lecithin vesicular carriers for transdermal delivery of cyclosporin A
58. Effect of current density on pharmacokinetics following continuous or intermittent input from a fentanyl electrotransport system
59. Iontophoresis - recent developments
60. Passive enhancement strategies in topical and transdermal drug delivery
61. Hydration and topical corticosteroid absorption
62. Application of an oily gel formed by hydrogenated soybean phospholipids as a percutaneous absorption-type ointment base
63. Physical chemical analysis of percutaneous absorption process
64. Mechanistic aspects of iontophoresis in human epidermal membrane
65. The hair follicle as a gene therapy target
66. Electro-incorporation of microcarriers as a method for the transdermal delivery of large molecules
67. Use of occluded hydrocolloid patches
68. Classification of percutaneous penetration enhancers: a conceptual diagram
69. Classification of penetration enhancers: a conceptual diagram
70. The effect of ultrasound application on skin metabolism of prednisolone 21-acetate
71. Membrane penetration enhancement of ibuprofen using supersaturation
72. Spatially constrained skin electroporation with sodium thiosulfate and urea creates transdermal microconduits
73. Microfabrication of individual 200 μm diameter transdermal microconduits using high voltage pulsing in salicylic acid and benzoic acid
74. Effects of iontophoresis and electroporation on the stratum corneum - review of the biophysical studies
75. Electrically-enhanced transdermal delivery of domperidone
76. Synergistic effects of chemical enhancers and therapeutic ultrasound on transdermal drug delivery
77. Physicochemical studies of lidocaine-menthol binary systems for enhanced membrane transport
78. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery
79. Influence of supersaturation on the thermodynamic effect of bupranolol after dermal administration using microemulsions as vehicle
80. Enhancement of transdermal delivery by superfluous thermodynamic potential. I. Thermodynamic analysis of nifedipine transport across the lipoidal barrier
81. Enhancement of transdermal delivery by superfluous thermodynamic potential. II. In vitro-in vivo correlation of percutaneous nifedipine transport
82. Enhancement of transdermal delivery by superfluous thermodynamic potential. III. Percutaneous absorption of nifedipine in rats
83. Phonophoresis
84. Synergistic effect of electric field and ultrasound on transdermal transport
85. Biomaterials in drug delivery and tissue engineering: one laboratory's experience
86. Combined effect of low frequency ultrasound and iontophoresis: application for transdermal heparin delivery
87. Topical drug delivery in humans with a single photomechanical wave
88. The role of electroosmotic flow on in vitro transdermal iontophoresis
89. Selection and use of crystallisation inhibitors for matrix-type transdermal drug-delivery systems containing sex steroids
90. Use of X-ray crystallography for the characterisation of single crystals grown in steroid containing transdermal drug delivery systems
91. Non-invasive assessment and control of ultrasound-mediated membrane permeabilisation
92. Transdermal delivery of macromolecules using skin electroporation
93. Microfabricated microneedles for gene and drug delivery
94. Preparation and characterisation of urea niosomes - in vitro and in vivo studies
95. A microinfusor device for the delivery of therapeutic levels of peptides and macromolecules
96. Estradiol permeation through human skin and silastic membrane: effects of propylene glycol and supersaturation
97. Ion-pair formation as a strategy to enhance topical delivery of salicylic acid
98. Effect of ion pairing with alkylamines on the in vitro dermal penetration and local tissue disposition of salicylates
99. Vesicular carriers for topical delivery
100. Low intensity ultrasound as a probe to elucidate the relative follicular contribution to total transdermal absorption
101. Delipidization of the cutaneous permeability barrier and percutaneous penetration
102. High-frequency sonophoresis: permeation pathways and structural basis for enhanced permeation
103. Ultrastructural effects of some solvents and vehicles on the stratum corneum and other skin components: evidence for an 'extended mosaic-partitioning model of the skin barrier'
104. Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil
105. Biodisposition of liposome-encapsulated active ingredients applied on the skin
106. Liposomes: a selective drug delivery system for the topical route of administration. I. Lotion dosage form
107. Liposomes: a selective drug delivery system for the topical route of administration: gel dosage form
108. Transdermal iontophoresis of gonadotropin releasing hormone and two analogues
109. Needle-free non-adjuvanted skin immunization by electroporation-enhanced transdermal delivery of diphtheria toxoid and a candidate peptide vaccine against hepatitis B virus
110. Synergistic effect of enhancers for transdermal drug delivery
111. Ultrasound-mediated transdermal protein delivery
112. Transdermal drug delivery using low-frequency sonophoresis
113. Transdermal extraction of analytes using low-frequency ultrasound
114. Analysis of ultrasonically extracted interstitial fluid as a predictor of blood glucose levels
115. A mechanistic study of ultrasonically enhanced transdermal drug delivery
116. Determination of threshold energy dose for ultrasound-induced transdermal drug transport
117. Low frequency sonophoresis: a noninvasive method of drug delivery and diagnostics
118. Synergistic effect of low-frequency ultrasound and sodium lauryl sulphate on transdermal transport
119. Magnetophoresis: an approach to enhance transdermal drug diffusion
120. Transdermal drug delivery: overcoming the skin's barrier function
121. Drug release studies on an oil-water emulsion based on a eutectic mixture of lidocaine and prilocaine as the dispersed phase
122. Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin
123. Evidence that oleic acid exists in a separate phase within stratum corneum lipids
124. Transdermal immunization with large proteins by means of ultradeformable drug carriers
125. Quantitative description of the effect of molecular size upon electroosmotic flux enhancement during iontophoresis for a synthetic membrane and human epidermal membrane
126. The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro
127. Effect of supersaturation on membrane transport: 2. Piroxicam
128. Supersaturated solutions evaluated with an in vitro stratum corneum tape stripping technique
129. Influence of the fluidity of liposome compositions on percutaneous absorption
130. The role of electroosmosis in transdermal iontophoresis
131. Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier and prolongation of local pain insensitivity by anesthetic liposomes
132. A practical assessment of transdermal drug delivery by skin electroporation
133. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery
134. Transdermal delivery of heparin by skin electroporation
135. Imaging of transport pathways across human stratum corneum during high-voltage and low-voltage electrical exposures
136. Effect of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate
137. Chirality and its implications in transdermal drug development
138. Mechanisms of a phosphorothioate oligonucleotide delivery by skin electroporation
139. Parameters controlling topical delivery of oligonucleotides by electroporation
140. Electroporation-mediated delivery of 3′-protected phosphodiester oligodeoxynucleotides to the skin
141. Pulsatile transdermal delivery of LHRH using electroporation: drug delivery and skin toxicology
142. The electrostability and electrically assisted delivery of an organophosphate pretreatment (physostigmine) across human skin in vitro
143. Induction of antigen-specific CD8+T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine
144. Iontophoresis
145. Reverse iontophoresis - parameters determining electroosmotic flow: 1. pH and ionic strength
146. A controlled-release microchip
147. Bioavailability following transdermal powdered delivery (TPD) of radiolabeled inulin to hairless guinea pigs
148. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery
149. Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin
150. Transport of ionic species in skin: contribution of pores to the overall skin conductance
151. Liposomes as a topical delivery system: the role of size on transport studied by the EPR imaging
152. On the mechanisms of in vitro and in vivo phonophoresis
153. Baseline studies on iontophoretic transport in hairless mouse skin: the effect of applied voltage drop and pH on the iontophoresis of a model weak electrolyte
154. Effect of current density on the iontophoretic permeability of benzyl alcohol and surface characteristics of human epidermis
155. Permeation enhancers for drug delivery
156. Ionisation and the effect of absorption enhancers on transport of salicylic acid through silastic rubber and human skin
157. Characterisation of complex coacervates of some tricyclic antidepressants and evaluation of their potential for enhancing transdermal flux
158. Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen
159. Mechanistic study into the enhanced transdermal permeation of a model β-blocker, propranolol, by fatty acids: a melting point depression effect
160. Passive drug diffusion via standardized skin mini-erosion; Methodological aspects and clinical findings with new device
161. Transdermal delivery of insulin to aloxan-diabetic rabbits by ultrasound exposure
162. Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device
163. Measurement of glucose in diabetic subjects using non-invasive transdermal extraction
164. Electropermeabilization of cell membranes
165. Ethosomes - novel vesicular carriers for enhanced delivery: characterisation and skin penetration properties
166. Enhanced delivery of drugs into and across the skin by ethosomal carriers
167. Enhanced delivery of drugs into and across the skin by ethosomal carriers
168. Methods of quantitative determination of drug localized in the skin
169. Modulation of caffeine delivery by carrier design: liposomes versus permeation enhancers
170. Sebaceous-gland deposition of isotretinoin after topical application: An in vitro study using human facial skin
171. Skin penetration-enhancing effects of drugs by phonophoresis
172. The dermal delivery of lignocaine: influence of ion pairing
173. Transdermal delivery of fentanyl by electroporation II. Mechanisms involved in drug transport
174. Macromolecules as novel transdermal transport enhancers for skin electroporation
175. Factors affecting transdermal delivery of metoprolol by electroporation
176. Transdermal delivery of fentanyl: rapid onset of analgesia using skin electroporation
177. In vivo efficacy and safety of skin electroporation
178. DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge
179. Effect of sodium dodecyl sulphate on iontophoresis of hydrocortisone across hairless mouse skin
180. Transdermal delivery of cyclosporin-A coevaporate using electroporation technique
181. Controlled topical delivery of cyclosporin-A from nonionic liposomal formulations: mechanistic aspects
182. Iontophoresis facilitated transdermal delivery of verapamil. II. Factors affecting reversibility of skin permeability
183. Electroporation of cells and tissues
184. Heparin alters transdermal transport associated with electroporation
185. Targeted follicular delivery of macromolecules via liposomes
186. Penetration enhancement by skin hydration
187. Terpenes and the lipid-protein partitioning theory of skin penetration enhancement
188. The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (estradiol) and hydrophilic (5-fluorouracil) drugs
189. Transdermal transport of DNA antisense oligonucleotides by electroporation
190. Creation of transdermal pathways for macromolecule transport by skin electroporation and a low toxicity, pathway-enlarging molecule
191. Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: an approach to gene therapy of skin ageing and other diseases
192. In vivo transdermal delivery of large molecules by pressure-mediated electroincorporation and electroporation: a novel method for drug and gene delivery